# Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer

> **NCT04457284** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 18 (actual)

## Conditions studied

- Colorectal Adenocarcinoma

## Interventions

- **DRUG:** Temozolomide (TMZ)
- **DRUG:** Cisplatin
- **DRUG:** Nivolumab

## Key facts

- **NCT ID:** NCT04457284
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-11-18
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04457284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04457284, "Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04457284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*